These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells. Luksiene Z; Eggen I; Moan J; Nesland JM; Peng Q Cancer Lett; 2001 Aug; 169(1):33-9. PubMed ID: 11410323 [TBL] [Abstract][Full Text] [Related]
24. 5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line. Vena FC; Turchiello RF; Laville I; Pigaglio S; Blais J; Tedesco AC Lasers Med Sci; 2004; 19(2):119-26. PubMed ID: 15340863 [TBL] [Abstract][Full Text] [Related]
25. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Casas A; Fukuda H; Di Venosa G; Batlle A Br J Cancer; 2001 Jul; 85(2):279-84. PubMed ID: 11461090 [TBL] [Abstract][Full Text] [Related]
26. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Ross EV; Romero R; Kollias N; Crum C; Anderson RR Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660 [TBL] [Abstract][Full Text] [Related]
28. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin. Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274 [TBL] [Abstract][Full Text] [Related]
29. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug. Curnow A; Perry A; Wood M Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949 [TBL] [Abstract][Full Text] [Related]
30. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Moan J; Ma LW; Juzeniene A; Iani V; Juzenas P; Apricena F; Peng Q Int J Cancer; 2003 Jan; 103(1):132-5. PubMed ID: 12455066 [TBL] [Abstract][Full Text] [Related]
31. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842 [TBL] [Abstract][Full Text] [Related]
32. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Choudry K; Brooke RC; Farrar W; Rhodes LE Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205 [TBL] [Abstract][Full Text] [Related]
33. The influence of temperature on 5-aminolevulinic acid-based photodynamic reaction in keratinocytes in vitro. Yang J; Chen AC; Wu Q; Jiang S; Liu X; Xiong L; Xia Y Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):83-8. PubMed ID: 20415739 [TBL] [Abstract][Full Text] [Related]
34. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. Uehlinger P; Zellweger M; Wagnières G; Juillerat-Jeanneret L; van den Bergh H; Lange N J Photochem Photobiol B; 2000 Jan; 54(1):72-80. PubMed ID: 10739146 [TBL] [Abstract][Full Text] [Related]
35. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Iinuma S; Farshi SS; Ortel B; Hasan T Br J Cancer; 1994 Jul; 70(1):21-8. PubMed ID: 8018536 [TBL] [Abstract][Full Text] [Related]
36. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130 [TBL] [Abstract][Full Text] [Related]
37. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy. Anayo L; Magnussen A; Perry A; Wood M; Curnow A Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761 [TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration. Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254 [TBL] [Abstract][Full Text] [Related]
39. On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin. Uehlinger P; Ballini JP; van den Bergh H; Wagnières G Photochem Photobiol; 2006; 82(4):1069-76. PubMed ID: 17205631 [TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines. Wu RW; Yow CM; Wong CK; Lam YH Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):254-63. PubMed ID: 21864799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]